Quaker Houghton manufactures and sells a variety of industrial process fluids... Show more
Quaker Houghton's third-quarter report carries weight because it shows whether the specialty industrial process fluids maker can keep converting its diversified global footprint into consistent profit growth. The quarter marked a fifth consecutive period of year-over-year profitability improvement and a second straight record for adjusted EBITDA, underscoring the company's ability to win new business even as end markets in regions such as EMEA (Europe, the Middle East, and Africa) remain pressured by geopolitical tensions. For investors, the results offer a read on industrial demand, raw material cost trends, and the progress of management's transformation initiatives heading into 2027.
Quaker Houghton reported third-quarter 2026 net sales of $544.5 million, a 10% increase from $493.8 million in the prior-year quarter and ahead of the roughly $522.9 million consensus estimate. Sales volumes rose 3%, while pricing and product mix improved 7%.
GAAP net income attributable to Quaker Chemical Corporation was $30.0 million, versus $30.5 million a year earlier, with GAAP diluted EPS of $1.73 compared with $1.75. On a non-GAAP basis, diluted EPS was $2.39, up 15% from $2.08 and well above the $2.10 consensus forecast. Adjusted EBITDA increased 8% to a record $89.8 million.
By segment, Americas net sales grew 14% to $254.0 million, EMEA rose 6% to $152.5 million, and Asia/Pacific advanced 9% to $138.1 million. Net cash provided by operating activities for the first nine months of 2026 was $47.6 million, down from $89.9 million a year earlier. As of September 30, total gross debt was $894.6 million, cash and equivalents were $167.0 million, and net debt was approximately $727.6 million, roughly 2.3 times trailing twelve-month adjusted EBITDA.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your search and uncover potential opportunities aligned with your strategy.
Heading into the report, sentiment was cautiously optimistic, with analysts expecting adjusted EPS of $2.10 and revenue near $522.9 million. The company's top- and bottom-line beats, anchored by a second consecutive record for adjusted EBITDA, reinforced the narrative that Quaker Houghton is converting above-market growth into higher earnings. Investor attention also focused on management's outlook, which flagged sequential softness in the fourth quarter on typical holiday-driven seasonal patterns in North America and EMEA, along with elevated raw material costs tied to Middle East conflict. That guidance likely tempered enthusiasm even as the reported quarter came in ahead of expectations.
Looking ahead, management expects fourth-quarter revenue and adjusted EBITDA to improve year over year but decline sequentially from the third quarter's record level, consistent with normal seasonal demand around the holidays in North America and EMEA.
Asia is expected to remain soft as geopolitical and economic uncertainty weighs on industrial demand in China, while global raw material costs are anticipated to stay elevated through year-end amid the Middle East conflict. Investors should watch how pricing actions and product mix offset those input-cost pressures.
Other factors worth monitoring include the trajectory of new business wins across the Americas, EMEA, and Asia/Pacific segments; the pace of the company's transformation initiatives; and balance sheet developments, including the roughly 2.3-times net-debt-to-adjusted-EBITDA leverage ratio. Progress on these fronts will help determine whether Quaker Houghton can carry its earnings momentum into 2027.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a company, which engages in the business of developing, producing and marketing formulated chemical specialty products
Industry ChemicalsSpecialty